FLT3

下级目录

NameC

SGI-1776 free base

SIM010603

SU-5614

KRC-108

AKN-028

BPR1J-097

BPR1J-340

FLX925 (AMG-925)

UNC-2025

G-749

CGP52421

AFG210

AAE871

AFG206

Ast-487

XL999

N-(1,3-Benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidin-4-yl-1-piperazinecarbothioamide

AUZ454

FI-700

LBW242

TTT-3002

AZD-2932

4SC-203

LY2457546

TG02 (SB1317)

PACRITINIB

SB1578

2-(3,4-Dimethoxy-benzoylamino)-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxylic acid amide

3-PHENYL-1H-BENZOFURO[3,2-C]PYRAZOLE

LESTAURTINIB

Tandutinib

AZD1152-HQPA

Linifanib

目录项下的产品

1000669-72-6 / MFCD100669726
KW-2449 is a novel multikinase inhibitor, which suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation. Recent research showed that HDACIs increase KW-2449 lethality in Bcr/Abl(+) cells in association with inhibition of Bcr/Abl, generation of ROS, and induction of DNA damage. This strategy preferentially targets primary Bcr/Abl(+) hematopoietic cells and exhibits enhanced in vivo activity. Combining KW-2449 with HDACIs warrants attention in IM-resistant Bcr/Abl(+) leukemias. (source: Clin Cancer Res. 2011 May 15;17(10):3219-32. Epub 2011 Apr 7.).
NameC

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

1025065-69-3 / MFCD125065693
SGI-1776
N-[(1-甲基-4-哌啶基)甲基]-3-[3-(三氟甲氧基)苯基]-咪唑并[1,2-b]哒嗪-6-胺

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

中华人民共和国

1032265-67-0 / MFCD132265670
SIM010603 is a structurally novel, oral, multi-targeted receptor tyrosine kinase inhibitor. SIM010603 inhibited stem cell factor receptor (Kit), vascular endothelial growth factor receptor-2 (VEGFR-2), platelet-derived growth factor receptor-β (PDGFR-β), glial cell line-derived neurotrophic factor receptor (Rearranged during Transfection; RET), and Fms-like tyrosine kinase-3 (FLT3) with IC(50) values between 5.0 and 68.1 nmol/l. SIM010603 inhibited the phosphorylation of PDGFR-β and VEGFR-2. Moreover, SIM010603 inhibited endothelial cell proliferation, endothelial cells chemotaxis, and corneal angiogenesis.

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

1055412-47-9 / MFCD155412479
SU5614
(Z)-5-氯-3-((3,5-二甲基-1H-吡咯-2-基)亚甲基)吲哚啉-2-酮

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

1146944-35-5 / MFCD246944355
KRC-108

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

1175017-90-9 / MFCD275017909
AKN-028

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

1327167-19-0 / MFCD427167190
BPR1J-097
4-(4-甲基哌嗪-1-基)-N-(5-(3-(苯磺酰胺基)苯基)-1H-吡唑-3-基)苯甲酰胺

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

中华人民共和国

1395051-72-5 / MFCD495051725
BPR1J-340

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

1401033-86-0 / MFCD501033860
FLX925 (AMG-925)

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

1429881-91-3 / MFCD529881913
UNC-2025
反式-4-(2-(丁胺基)-5-(4-((4-甲基哌嗪-1-基)甲基)苯基)-7H-吡咯并[2,3-d]嘧啶-7-基)环己醇

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

1457983-28-6 / MFCD557983286
8-Bromo-2-((1-Methylpiperidin-4-Yl)Amino)-4-((4-Phenoxyphenyl)Amino)Pyrido[4,3-D]Pyrimidin-5(6H)-One
8-溴-2-((1-甲基哌啶-4-基)氨基)-4-((4-苯氧基苯基)氨基)吡啶并[4,3-d]嘧啶-5(6H)-酮

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

179237-49-1 / MFCD79237491
CGP52421

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

228400-22-4 / MFCD28400224
AFG210

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

289479-07-8 / MFCD89479078
AAE871 is a type I FLT3 inhibitor.

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

630122-37-1 / MFCD30122371
AFG206

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

630124-46-8 / MFCD30124468
AST487, also known as NVP-AST487, is a RET kinase inhibitor/FLT3 inhibitor. The RET kinase has emerged as a promising target for the therapy of medullary thyroid cancers (MTC) and of a subset of papillary thyroid cancers. NVP- AST487 has an IC(50) of 0.88 mumol/L on RET kinase, inhibits RET autophosphorylation and activation of downstream effectors, and potently inhibited the growth of human thyroid cancer cell lines with activating mutations of RET but not of lines without RET mutations. NVP- AST487 induced a dose-dependent growth inhibition of xenografts of NIH3T3 cells expressing oncogenic RET, and of the MTC cell line TT in nude mice. NVP- AST487 inhibited calcitonin gene expression in vitro in TT cells, in part, through decreased gene transcription.
1-(4-((4-乙基哌嗪-1-基)甲基)-3-(三氟甲基)苯基)-3-(4-((6-(甲基氨基)嘧啶-4-基)氧基)苯基)脲

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

705946-27-6 / MFCD05946276
(Z)-5-((1-Ethylpiperidin-4-yl)amino)-3-((3-fluorophenyl)(5-methyl-1H-imidazol-2-yl)methylene)indolin-2-one
(Z)-5-((1-乙基哌啶-4-基)氨基)-3-((3-氟苯基)(5-甲基-1H-咪唑-2-基)亚甲基)吲哚啉-2-酮

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

中华人民共和国

850879-09-3 / MFCD50879093
N-(Benzo[D][1,3]Dioxol-5-Ylmethyl)-4-(Benzofuro[3,2-d]Pyrimidin-4-Yl)Piperazine-1-Carbothioamide
N-(苯并[d][1,3]二氧杂环戊烷-5-基甲基)-4-(苯并呋喃并[3,2-d]嘧啶-4-基)哌嗪-1-甲硫酰胺

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

853299-07-7 / MFCD53299077
1-(4-((2-Aminopyrimidin-4-Yl)Oxy)Phenyl)-3-(4-((4-Methylpiperazin-1-Yl)Methyl)-3-(Trifluoromethyl)Phenyl)Urea
1-(4-(2-氨基嘧啶-4-基氧基)苯基)-3-(4-((4-甲基哌嗪-1-基)甲基)-3-三氟甲基苯基)脲

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

866883-79-6 / MFCD66883796
FI-700

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

867324-12-7 / MFCD67324127
LBW242

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

871037-95-5 / MFCD71037955
TTT-3002

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

883986-34-3 / MFCD83986343
2-(4-((6,7-Dimethoxyquinazolin-4-yl)oxy)phenyl)-N-(1-isopropyl-1H-pyrazol-4-yl)acetamide
2-(4-((6,7-二甲氧基喹唑啉-4-基)氧基)苯基)-N-(1-异丙基-1H-吡唑-4-基)乙酰胺

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

895533-09-2 / MFCD95533092
4SC-203

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

908265-94-1 / MFCD008265941
LY2457546 is a potent and orally bioavailable inhibitor of multiple receptor tyrosine kinases involved in angiogenic and tumorigenic signalling. LY2457546 demonstrates potent activity against targets that include VEGFR2 (KDR), PDGFRβ, FLT-3, Tie-2 and members of the Eph family of receptors. In vivo, LY2457546 inhibited VEGF-driven autophosphorylation of lung KDR in the mouse and rat in a dose and concentration dependent manner. LY2457546 was well tolerated and exhibited efficacy in a 13762 syngeneic rat mammary tumor models. Additionally, LY2457546 caused complete regression of well-established tumors in an acute myelogenous leukemia (AML) FLT3-ITD mutant xenograft tumor model. The unique spectrum of target activity, potent in vivo anti-tumor efficacy in a variety of rodent and human solid tumor models, exquisite potency against a clinically relevant model of AML, and non-clinical safety profile justify the advancement of LY2457546 into clinical testing. (source: Invest New Drugs. 2012

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

937270-47-8 / MFCD037270478
TG02, also known as SB1317, is a novel small molecule potent CDK/JAK2/FLT3 inhibitor. It dose-dependently inhibits signaling pathways downstream of CDKs, JAK2 and FLT3 in cancer cells with the main targets being CDKs. TG02 is anti-proliferative in a broad range of tumor cell lines, inducing G1 cell cycle arrest and apoptosis. In vivo, TG02 exhibits favorable pharmacokinetics after oral dosing in xenograft models and accumulates in tumor tissues, inducing an effective blockade of both CDK and STAT signaling.

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

937272-79-2 / MFCD037272792
PACRITINIB
Pacritinib游离态

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

937273-04-6 / MFCD037273046
SB1578

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

301305-73-7 / MFCD00617269
2-(3,4-Dimethoxybenzamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxamide
2-(3,4-二甲氧基苯甲酰胺基)-4,5,6,7-四氢苯并[b]噻吩-3-甲酰胺

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

中华人民共和国
√

34823-86-4 / MFCD01416326
3-Phenyl-1H-Benzofuro[3,2-c]Pyrazole
3-苯基-1H-苯并呋喃并[3,2-c]吡唑

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

111358-88-4 / MFCD09837744
LESTAURTINIB

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

387867-13-2 / MFCD09954147
N-(4-Isopropoxyphenyl)-4-(6-Methoxy-7-(3-(Piperidin-1-Yl)Propoxy)Quinazolin-4-Yl)Piperazine-1-Carboxamide
N-(4-异丙氧基苯基)-4-(6-甲氧基-7-(3-(哌啶-1-基)丙氧基)喹唑啉-4-基)哌嗪-1-甲酰胺

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

722544-51-6 / MFCD10687152
3-[[7-[3-[Ethyl(2-Hydroxyethyl)Amino]Propoxy]-4-Quinazoline]Amino]-N-(3-Fluorophenyl)-1H-Pyrazole-3-Acetamide
5-[[7-[3-[乙基(2-羟基乙基)氨基]丙氧基]-4-喹唑啉]氨基]-N-(3-氟苯基)-1H-吡唑-3-乙酰胺

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

中华人民共和国
√

796967-16-3 / MFCD11840918
1-(4-(3-Amino-1H-Indazol-4-Yl)Phenyl)-3-(2-Fluoro-5-Methylphenyl)Urea
1-(4-(3-氨基-1H-吲唑-4-基)苯基)-3-(2-氟-5-甲基苯基)脲

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

中华人民共和国
√